Medtronic plc (MDT) — Analysis Summary
Medtronic plc (MDT) has a market cap of $115.16B with year-over-year revenue growth of +8.4%. Net margin stands at 13.2%. The stock trades at a P/E ratio of 24.0.
Key Takeaways
- Revenue changed +8.4% year-over-year
- Net margin of 13.2%
- P/E ratio of 24.0
Compared to other companies in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector, MDT posted revenue growth of +8.4% and trades at a P/E of 24.0.
Medtronic plc (MDT)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
95,000
Headquarters
GALWAY
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$2.88
Dividend Yield
3.16%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.